Phenotype |
System |
Allele |
Zyg |
Sex |
Life Stage |
P Value |
decreased circulating amylase level
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
2.18×10-06
|
decreased circulating triglyceride level
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
7.47×10-05
|
decreased bone mineral density
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
8.30×10-12
|
decreased erythrocyte cell number
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
5.46×10-06
|
decreased bone mineral content
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
5.03×10-06
|
preweaning lethality, complete penetrance
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HOM
|
|
Early adult
|
0.00
|
increased mean corpuscular hemoglobin
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
8.75×10-06
|
increased circulating iron level
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
2.99×10-05
|
decreased circulating calcium level
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
2.23×10-06
|
increased KLRG1-positive NK cell number
|
|
Fam160a1tm1b(EUCOMM)Wtsi
|
HET
|
|
Early adult
|
0.00
|
Select physiological systems to view:
Viewing: all phenotypes
Select physiological systems to view:
Viewing: all phenotypes